Matrix metalloproteinase 2 as a pharmacological target in heart failure
PR Gonçalves, LD Nascimento, RF Gerlach… - Pharmaceuticals, 2022 - mdpi.com
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …
Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations
Various pathophysiological mechanisms have been implicated in hypertension, but those
resulting in vascular dysfunction and remodeling are critical and may help to identify critical …
resulting in vascular dysfunction and remodeling are critical and may help to identify critical …
Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension
VA Belo, DA Guimarães, MM Castro - Journal of vascular research, 2016 - karger.com
For vascular remodeling in hypertension, it is essential that vascular smooth muscle cells
(VSMCs) reshape in order to proliferate and migrate. The extracellular matrix (ECM) needs …
(VSMCs) reshape in order to proliferate and migrate. The extracellular matrix (ECM) needs …
Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke
Y Chen, F Shen, J Liu, GY Yang - Stroke and vascular Neurology, 2017 - svn.bmj.com
Stroke is the second leading cause of mortality and morbidity worldwide. Early intervention
is of great importance in reducing disease burden. Since the conventional risk factors cannot …
is of great importance in reducing disease burden. Since the conventional risk factors cannot …
Matrix metalloproteinases are involved in cardiovascular diseases
A Azevedo, AF Prado, RC Antonio… - Basic & Clinical …, 2014 - Wiley Online Library
This MiniReview describes the essential biochemical and molecular aspects of matrix
metalloproteinases (MMP s) and briefly discusses how they engage in different diseases …
metalloproteinases (MMP s) and briefly discusses how they engage in different diseases …
Circulating matrix metalloproteinases and their inhibitors in hypertension
Growing experimental evidence indicates that matrix metalloproteinases (MMPs) are
implicated in many cardiovascular diseases including hypertension and its chronic …
implicated in many cardiovascular diseases including hypertension and its chronic …
[HTML][HTML] Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension
Hypertension is associated with well known structural and functional alterations in both
resistance and conduit arteries, which may be the result from long-lasting high blood …
resistance and conduit arteries, which may be the result from long-lasting high blood …
Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension
Hypertension is characterized by maladaptive vascular remodeling and enhanced oxidative
stress in the vascular wall. Peroxynitrite may directly activate latent matrix metalloproteinase …
stress in the vascular wall. Peroxynitrite may directly activate latent matrix metalloproteinase …
Matrix metalloproteinases as drug targets in preeclampsia
A CT Palei, J P. Granger… - Current drug targets, 2013 - benthamdirect.com
Preeclampsia is an important syndrome complicating pregnancy. While the pathogenesis of
preeclampsia is not entirely known, poor placental perfusion leading to widespread …
preeclampsia is not entirely known, poor placental perfusion leading to widespread …
Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations
MM Castro, JE Tanus-Santos - Current drug targets, 2013 - ingentaconnect.com
A group of proteases, the matrix metalloproteinases (MMPs) are well known for their
capacity to degrade extracellular matrix (ECM) proteins. Particularly MMP-2 and MMP-9 …
capacity to degrade extracellular matrix (ECM) proteins. Particularly MMP-2 and MMP-9 …